Psychotherapy

Exercise Should Be Prescribed for Depression, a New Report by The John W Brick Mental Health Foundation Recommends

Tuesday, June 15, 2021 - 1:31pm

In addition to the staggering numbers, access to mental health care is limited, and almost exclusively focused on medication, psychotherapy, and hospitalization.

Key Points: 
  • In addition to the staggering numbers, access to mental health care is limited, and almost exclusively focused on medication, psychotherapy, and hospitalization.
  • The John W. Brick Mental Health Foundation was established to expand our approaches to mental and emotional well-being, including exercise, nutrition and mind-body practices.
  • Move Your Mental Health ( https://www.johnwbrickfoundation.org/move-your-mental-health-report/ ), written by the JWB Foundation science team, answers this question with a resounding yes, particularly where exercise is concerned.
  • Through research, programs and collaboration, the John W. Brick Foundation aims to give individuals struggling with mental health issues the possibility of enjoying a better life.

Awakn Life Sciences to Participate in the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference

Thursday, June 10, 2021 - 1:00pm

Toronto, Ontario--(Newsfile Corp. - June 10, 2021) - Awakn Life Sciences Inc. (Awakn), a biotechnology company with clinical operations researching, developing, and delivering psychedelic medicine to treat Addiction, announced today that Anthony Tennyson, Chief Executive Officer, and Professor Celia Morgan, Head of Awakn's Ketamine-Assisted Psychotherapy for Addiction Practice, will participate in H.C. Wainwright's Psychedelics in Psychiatry and Beyond Virtual Conference panels on Thursday, June 17, 2021.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - June 10, 2021) - Awakn Life Sciences Inc. (Awakn), a biotechnology company with clinical operations researching, developing, and delivering psychedelic medicine to treat Addiction, announced today that Anthony Tennyson, Chief Executive Officer, and Professor Celia Morgan, Head of Awakn's Ketamine-Assisted Psychotherapy for Addiction Practice, will participate in H.C. Wainwright's Psychedelics in Psychiatry and Beyond Virtual Conference panels on Thursday, June 17, 2021.
  • For more information regarding the conference, or to schedule a one-on-one meeting with Awakn's management team, please contact KCSA Strategic Communications at Awakn@KCSA.com or your H.C. Wainwright representatives directly.
  • About Awakn Life Sciences Inc.
    Awakn Life Sciences is a biotechnology company with clinical operations researching, developing, and delivering psychedelic medicine to treat Addiction.
  • Awakn is integrating psychedelic medicine into mainstream healthcare through Research, Digital, Clinics, and Ecosystems.

Cybin Launches EMBARK and Co-Sponsors First Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Burnout and Distress with Psychedelic-Assisted Psychotherapy

Tuesday, June 8, 2021 - 12:00pm

The study will aim to treat symptoms of depression, anxiety, burnout and post-traumatic stress among frontline doctors, nurses and healthcare professionals.

Key Points: 
  • The study will aim to treat symptoms of depression, anxiety, burnout and post-traumatic stress among frontline doctors, nurses and healthcare professionals.
  • To support the initiative, Cybins Chief Clinical Officer, Alex Belser, PhD and Bill Brennan, PhD (candidate) developed EMBARK.
  • The development of EMBARK has been guided by leading process evidence for the clinical efficacy of psychedelic-assisted psychotherapy and demonstrated theories of therapeutic action to support healing.
  • EMBARK was designed as a transdiagnostic psychotherapy model that can be adapted to address a range of clinical indications and populations.

Anna Svetchnikov, LMFT is recognized by Continental Who's Who

Monday, June 7, 2021 - 6:55pm

SWAMPSCOTT, Mass., June 7, 2021 /PRNewswire/ --Anna Svetchnikov, LMFT, is being recognized by Continental Who's Who as a Top Executive for her outstanding achievements in marriage, family therapy, and social work.

Key Points: 
  • SWAMPSCOTT, Mass., June 7, 2021 /PRNewswire/ --Anna Svetchnikov, LMFT, is being recognized by Continental Who's Who as a Top Executive for her outstanding achievements in marriage, family therapy, and social work.
  • Devoted to transforming child and family support networks, Anna Svetchnikov, LMFT, is a well-respected licensed marriage and family therapist, social worker, and author.
  • In 2003, she enrolled in the Psychology program at the University of Massachusetts in Boston.
  • Ms. Svetchnikov dedicates this honorable recognition to her mom, Vera, her husband, Michael, and her children, Anthony, Adrian, and Apollo.

XRHealth Announces XR (Augmented/Virtual Reality) Therapy to Address Mental Health Conditions and Substance Abuse

Tuesday, June 1, 2021 - 12:00pm

BOSTON, June 1, 2021 /PRNewswire/ -- XRHealth ,the leader in extended reality and therapeutic applications, announces today that the XRHealth XR (augmented/virtual reality) therapy platform will now treat mental health conditions as well as substance abuse issues.

Key Points: 
  • BOSTON, June 1, 2021 /PRNewswire/ -- XRHealth ,the leader in extended reality and therapeutic applications, announces today that the XRHealth XR (augmented/virtual reality) therapy platform will now treat mental health conditions as well as substance abuse issues.
  • XRHealth found a similar pattern when treating patients for physical/occupational therapy many patients had coexisting symptoms of stress and anxiety.
  • XRHealth is now treating those conditions separately with psychologists, psychiatrists, and social workers who are all using the XRHealth XR Therapy platform as the primary treatment device.
  • To address this heightened issue, XRHealth is now treating substance abuse in both individual counseling and group therapy.

Workplace Stress Management Market to Reach $11.49 Bn, Globally, by 2027 at 5.9% CAGR: Allied Market Research

Monday, May 31, 2021 - 2:00pm

According to the report, the global workplace stress management industry generated $8.21 billion in 2019, and is estimated to reach $11.49 billion by 2027, witnessing a CAGR of 5.9% from 2020 to 2027.

Key Points: 
  • According to the report, the global workplace stress management industry generated $8.21 billion in 2019, and is estimated to reach $11.49 billion by 2027, witnessing a CAGR of 5.9% from 2020 to 2027.
  • Surge in competition at workplace and rise in awareness of stress management drive the growth of the global workplace stress management market.
  • Based on service, the stress assessment segment contributed to nearly two-fifths of the global workplace stress management market in 2019, and is estimated to maintain its lead position during the forecast period.
  • This is due to prominence of stress assessment techniques and introduction of stress management programs in organizations.

Nystrom & Associates to Open a New Clinic in Alexandria

Friday, May 28, 2021 - 3:00pm

ALEXANDRIA, Minn., May 28, 2021 /PRNewswire/ -- Nystrom & Associates, Ltd., one of the Nation's largest behavioral health and substance use disorder providers announces the opening of its new clinic in Alexandria at 305 30th Ave. W, Alexandria, MN 56308.

Key Points: 
  • ALEXANDRIA, Minn., May 28, 2021 /PRNewswire/ -- Nystrom & Associates, Ltd., one of the Nation's largest behavioral health and substance use disorder providers announces the opening of its new clinic in Alexandria at 305 30th Ave. W, Alexandria, MN 56308.
  • Nystrom's new outpatient clinic will serve all ages and will offer the Alexandria Community and surrounding areas services for: Psychiatry/Medication Management, Therapy, Substance Use Disorder treatment (SUD), and Dialectical Behavioral Therapy (DBT).
  • "We're very excited and honored to be expanding these very important services into the Alexandria community and surrounding areas.
  • We have a phenomenal team of clinical providers and management who came together to make this possible," Peter Nystrom, Chief Commercial Officer of Nystrom & Associates noted.

Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board

Thursday, May 27, 2021 - 1:57pm

In this role, Dr. Fadiman will provide strategic guidance and direction to Wesanas scientific research efforts related to psychedelic-assisted psychotherapy to treat traumatic brain injury (TBI).

Key Points: 
  • In this role, Dr. Fadiman will provide strategic guidance and direction to Wesanas scientific research efforts related to psychedelic-assisted psychotherapy to treat traumatic brain injury (TBI).
  • Its very important me to ensure that the research on psychedelics is applied in the most effective way.
  • He has been involved in psychedelic research for more than fifty years, the last ten years uncovering and researching microdosing.
  • Wesana is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury (TBI).

Reulay Announces Results From Study of Virtual Reality Interventions for Workplace Stress and Anxiety

Thursday, May 27, 2021 - 12:07pm

Reulay, a virtual therapeutic platform using machine learning for stress and anxiety, has announced exciting results.

Key Points: 
  • Reulay, a virtual therapeutic platform using machine learning for stress and anxiety, has announced exciting results.
  • A study conducted by a multibillion-dollar health insurance company reports that the feasibility, safety, and efficacy of Reulays digital interventions met primary and secondary endpoints.
  • The results show that Reulays carefully constructed brain-based virtual journeys reduced negative mindsets, worry, nervousness, and the feeling of being on edgea big step towards eliminating workplace stress.
  • CEO Patrick Candela explained, Work is the scene of the crime when it comes to stress and anxiety.

Active-audio solution Bio Music One launches free track on App Store and Google Play

Thursday, May 27, 2021 - 8:38am

LONDON, May 27, 2021 /PRNewswire/ -- Bio Music Oneis active-audio technology integrated into in-house musical productions.

Key Points: 
  • LONDON, May 27, 2021 /PRNewswire/ -- Bio Music Oneis active-audio technology integrated into in-house musical productions.
  • Studies conducted by the WHOreveal an increase in signs of stress, depression and anxiety throughout society.
  • Users can now download the Bio Music One App and experience the benefits for themselves through a free track, the liberating "Bio Active Listening".
  • Bio Music One is the result of 20 years of research and development.